Trademark Search
Owners
SHIRE-NPS PHARMACEUTICALS, INC.
PREOTACT PARATHYROID HORMONE (RDNA ORIGIN) FOR INJECTION
failure to respond or late response
on 04 Feb 2017
Last Applicant/ Owned by
300 SHIRE WAY
LEXINGTON
MA
02421
Serial Number
86949110 filed on 22nd Mar 2016
Registration Number
N/A
Correspondent Address
Timothy H. Hiebert
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"PARATHYROID (RDNA ORIGIN) FOR INJECTION"
Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, infectious diseases, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, endocrine disorders, or bone metabolism disorders; pharmaceutical preparations for use in analgesia The mark consists of the letters "PREOTACT" in uppercase lRead More
Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, infectious diseases, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, endocrine disorders, or bone metabolism disorders; pharmaceutical preparations for use in analgesia
No 86949110
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
26.17.09 -
Curved line(s), band(s) or bar(s)
The mark consists of the letters "PREOTACT" in uppercase letters above "parathyroid hormone (rDNA origin) for injection". Curved lines are behind and below the words.
| Status Date | Action Taken |
|---|---|
| 06th Feb 2017 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| 04th Feb 2017 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 10th Aug 2016 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 08th Aug 2016 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 08th Aug 2016 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 04th Aug 2016 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 07th Jul 2016 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 07th Jul 2016 | NON-FINAL ACTION E-MAILED |
| 07th Jul 2016 | NON-FINAL ACTION WRITTEN |
| 30th Jun 2016 | ASSIGNED TO EXAMINER |
